Catalys Pacific, LLC
- SEC CIK
- 0002011385
Holdings, Q2 2026
Positions as of Jun 30, 2026, filed Aug 5, 2026.SEC
- Positions
- 2
- 0 vs. Q1 2026
- Total value
- $229.45M
- −$1.26M (−0.5%) vs. Q1 2026
Compare with Q1 2026: new, added, reduced and sold out
Positions
Long positions only. Changes compare share counts with Q1 2026.
| Security | Class | Shares | Value | % of portfolio | Change in shares | Action | History |
|---|---|---|---|---|---|---|---|
| MLYSMINERALYS THERAPEUTICS INC | COM | 7,903,838 | $213.25M | 92.94% | 00.0% | Unchanged | View |
| PHATPHATHOM PHARMACEUTICALS INC | COM | 1,493,854 | $16.21M | 7.06% | 00.0% | Unchanged | View |
13F filings by quarter
| Quarter | Filed | Positions | Total value | Changes | Filing |
|---|---|---|---|---|---|
| Q2 2026 | Aug 5, 2026 | 2 | $229.45M | vs. Q1 2026 | SEC |
| Q1 2026 | May 14, 2026 | 2 | $230.71M | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 10, 2026 | 2 | $310.54M | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 14, 2025 | 2 | $351.37M | vs. Q2 2025 | SEC |
| Q2 2025 | Aug 13, 2025 | 2 | $131.66M | vs. Q1 2025 | SEC |
| Q1 2025 | Aug 13, 2025Amended | 2 | $148.71M | vs. Q4 2024 | SEC |
| Q4 2024 | Feb 14, 2025 | 2 | $115.89M | vs. Q3 2024 | SEC |
| Q3 2024 | Nov 12, 2024 | 3 | $125.4M | vs. Q2 2024 | SEC |
| Q2 2024 | Aug 13, 2024 | 3 | $132.49M | vs. Q1 2024 | SEC |
| Q1 2024 | May 14, 2024 | 3 | $148.14M | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 14, 2024 | 3 | $106.67M | – | SEC |